Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia
Clinical trial NCT03172702 · COMPLETED
Trial details
- NCT number
- NCT03172702
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-04
- Primary completion
- 2019-07-06
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.